ARCHIVES

Control-Arm CML Patients In Phase III Gleevec Study Allowed To Switch.

This article is from The Cancer Letter archive.

Vol. 28 No. 04 | January 25, 2002

Download PDF Visit The Full Archive

Related Articles

Study Shows MammaPrint Test Can Predict 25-Year Risk Levels

February 28, 2014

FDA Approves Tamoxifen For DCIS Folowing Breast Surgery And Radiation.

July 28, 2000

Medenica’s Claims Of Association On CV, Brochures, Challenged By Some Institutions

April 30, 1993

M.D. Anderson Closes Trials following FDA Requests for Data

February 16, 1996

In Brief: DCT Reorganizing Some Labs, Branches, Plans to Establish Theirs; Weicker, Natcher Honored

January 17, 1986

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005